➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Baxter
Merck
Express Scripts
Colorcon

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

Captopril; hydrochlorothiazide - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for captopril; hydrochlorothiazide and what is the scope of patent protection?

Captopril; hydrochlorothiazide is the generic ingredient in five branded drugs marketed by Apothecon, Cosette, Ivax Sub Teva Pharms, Mylan, Vintage Pharms Llc, and Watson Labs, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for captopril; hydrochlorothiazide. One supplier is listed for this compound.

Summary for captopril; hydrochlorothiazide
Recent Clinical Trials for captopril; hydrochlorothiazide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
West China HospitalPhase 4
Vanderbilt University Medical CenterPhase 1/Phase 2
VA Office of Research and DevelopmentN/A

See all captopril; hydrochlorothiazide clinical trials

Pharmacology for captopril; hydrochlorothiazide

US Patents and Regulatory Information for captopril; hydrochlorothiazide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan CAPTOPRIL AND HYDROCHLOROTHIAZIDE captopril; hydrochlorothiazide TABLET;ORAL 074896-003 Dec 29, 1997 RX No No   Start Trial   Start Trial   Start Trial
Cosette CAPTOPRIL AND HYDROCHLOROTHIAZIDE captopril; hydrochlorothiazide TABLET;ORAL 074827-002 Dec 29, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Cosette CAPTOPRIL AND HYDROCHLOROTHIAZIDE captopril; hydrochlorothiazide TABLET;ORAL 074827-001 Dec 29, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for captopril; hydrochlorothiazide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Apothecon CAPOZIDE 50/15 captopril; hydrochlorothiazide TABLET;ORAL 018709-004 Oct 12, 1984   Start Trial   Start Trial
Apothecon CAPOZIDE 25/15 captopril; hydrochlorothiazide TABLET;ORAL 018709-001 Oct 12, 1984   Start Trial   Start Trial
Apothecon CAPOZIDE 25/25 captopril; hydrochlorothiazide TABLET;ORAL 018709-002 Oct 12, 1984   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
AstraZeneca
Baxter
Dow
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.